2023

Nastoupil, LJ, Hess, G, Pavlovsky, MA, Danielewicz, I, Freeman, J, Garcia-Sancho, AM, Glazunova, V, Grigg, A, Hou, JZ, Janssens, A, Kim, SJ, Masliak, Z, Mckay, P, Merli, F, Munakata, W, Nagai, H, Özcan, M, Preis, M, Wang, TY, Rowe, M, Tamegnon, M, Cir, R, Henninger, T, Curtis, M, Caces, DB, Thieblemont, C, Salles, G. Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma. BLOOD ADV 7 7141-7150. 28 nov 2023. 1 nov 2023. . F.I.:7,400 [doi:10.1182/bloodadvances.2023010298]

Zinzani, PL, Mayer, J, Flowers, CR, Bijou, F, De Oliveira, AC, Song, YQ, Zhang, QY, Merli, M, Bouabdallah, K, Ganly, P, Zhang, HL, Johnson, R, Garcia-Sancho, AM, Pulla, MP, Trneny, M, Yuen, S, Tilly, H, Kingsley, E, Tumyan, G, Assouline, SE, Auer, R, Ivanova, E, Kim, P, Huang, S, Delarue, R, Trotman, J. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma. J CLIN ONCOL 41 5107-. 20 nov 2023. . . F.I.:42,100 [doi:10.1200/JCO.23.00775]

Gómez-Vecino, A, Corchado-Cobos, R, Blanco-Gómez, A, García-Sancha, N, Castillo-Lluva, S, Martín-García, A, Mendiburu-Eliçabe, M, Prieto, C, Ruiz-Pinto, S, Pita, G, Velasco-Ruiz, A, Patino-Alonso, C, Galindo-Villardón, P, Vera-Pedrosa, ML, Jalife, J, Mao, JH, de Plasencia, GM, Castellanos-Martín, A, Sáez-Freire, MD, Fraile-Martín, S, Rodrigues-Teixeira, T, García-Macías, C, Galvis-Jiménez, JM, García-Sánchez, A, Isidoro-García, M, Fuentes, M, García-Cenador, MB, García-Criado, FJ, García-Hernández, JL, Hernández-García, MA, Cruz-Hernández, JJ, Rodríguez-Sánchez, CA, García-Sancho, AM, Pérez-López, E, Pérez-Martínez, A, Gutiérrez-Larraya, F, Cartón, AJ, García-Sáenz, JA, Patino-Garcia, A, Martín, M, Alonso-Gordoa, T, Vulsteke, C, Croes, L, Hatse, S, Van Brussel, T, Lambrechts, D, Wildiers, H, Chang, H, Holgado-Madruga, M, González-Neira, A, Sánchez, PL, Losada, JP. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk. CELLS-BASEL 12 -. 1 ago 2023. . . F.I.:5,100 [doi:10.3390/cells12151956]

García-Sancho, AM, Baile, M, Rodríguez, G, Dlouhy, I, Sancho, JM, Jarque, I, González-Barca, E, Salar, A, Espeso, M, Grande, C, Bergua, J, Montes-Moreno, S, Redondo, A, Enjuanes, A, Campo, E, López-Guillermo, A, Caballero, D. Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO. BRIT J HAEMATOL 203 202-211. 23 jul 2023. 1 jul 2023. . F.I.:5,100 [doi:10.1111/bjh.18989]
Zinzani, PL, Thieblemont, C, Melnichenko, V, Bouabdallah, K, Walewski, J, Majlis, A, Fogliatto, L, Garcia-Sancho, AM, Christian, B, Gulbas, Z, Özcan, M, Perini, GF, Ghesquieres, H, Shipp, MA, Thompson, S, Chakraborty, S, Marinello, P, Armand, P. Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170. BLOOD 142 141-145. 13 jul 2023. 1 jul 2023. . F.I.:21,000 [doi:10.1182/blood.2022019340]

Garcia-Sancho, AM, Rodriguez-Pinilla, SM, Domingo-Domenech, E, Climent, F, Sanchez-Garcia, J, Jimenez, JL, Piqueras, MGC, Castellvi, J, Gonzalez, AJ, de Villambrosia, SG, Codina, JG, Navarro, B, Rodriguez, G, Borrero, JJ, Fraga, M, Naves, A, Baeza, L, Cordoba, R. Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study. BRIT J HAEMATOL 203 182-193. 30 jun 2023. 1 jun 2023. . F.I.:5,100 [doi:10.1111/bjh.18941]

Jimenez-Ubieto, A, Martin-Munoz, A, Poza, M, Dorado, S, Garcia-Ortiz, A, Revilla, E, Sarandeses, P, Ruiz-Heredia, Y, Baumann, T, Rodriguez, A, Calbacho, M, Sanchez, PM, Pina, JMS, Garcia-Sancho, AM, Figaredo, G, Rufian, L, Rodriguez, M, Carneros, L, Martinez-Laperche, C, Bastos-Oreiro, M, Wang, CW, Cedena, MT, Rapado, I, de Toledo, P, Valeri, A, Ayala, R, Martinez-Lopez, J, Barrio, S. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients. FRONT IMMUNOL 14 -. 5 jun 2023. . . F.I.:5,700 [doi:10.3389/fimmu.2023.1188818]

Barca, EG, Tomas-Roca, L, Esteve, A, Rodriguez, M, Gato, L, Alonso-Alonso, R, Garcia-Sancho, AM, Cordoba, R, Monter-Rovira, A, Bastos-Oreiro, M, Burgues, JMB, Sayas, MJ, Alegria, MCV, Sanchez-Blanco, JJ, Pellicer, MR, Henriquez, HDL, de Ona, R, Cabezudo, ME, Infante, MS, Hernandez, JAQ, Sanz-Pamplona, R, Blanco, O, Mozos, A, Climent, F, Piris, MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AM J HEMATOL 98 134-138. 16 mar 2023. 1 mar 2023. . F.I.:10,100 [doi:10.1002/ajh.26904]